Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Clinical trial NCT05718466 · COMPLETED

Trial details

NCT number: NCT05718466
Sponsor: Henry Ford Health System
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent or Progressive Glioblastoma

Start date: 2010-11-01
Primary completion: 2016-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.